Triple

T6067883
Position Surface form Disambiguated ID Type / Status
Subject Tommy Thompson E135203 entity
Predicate notableWork P4 FINISHED
Object Medicare prescription drug benefit implementation E544646 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicare prescription drug benefit implementation | Statement: [Tommy Thompson, notableWork, Medicare prescription drug benefit implementation]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Medicare prescription drug benefit implementation
Context triple: [Tommy Thompson, notableWork, Medicare prescription drug benefit implementation]
  • A. Special Enrollment Periods for Medicare Part D
    Special Enrollment Periods for Medicare Part D are limited-time windows outside the standard enrollment period during which eligible individuals can sign up for or change their Medicare prescription drug coverage due to specific life events or circumstances.
  • B. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 chosen
    The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
  • C. Prescription Drug User Fee Act of 1992
    The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
  • D. 340B Drug Pricing Program
    The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
  • E. Medicare secondary payer rules
    Medicare secondary payer rules are federal regulations that determine when Medicare pays after another insurer (like employer group health plans, liability, no-fault, or workers’ compensation insurance) has primary responsibility for a beneficiary’s medical costs.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00879e8048190b690717d19c5bc03 completed March 22, 2026, 3:19 p.m.
NER Named-entity recognition batch_69c057403a8081908b593472fcc0d699 completed March 22, 2026, 8:55 p.m.
NED1 Entity disambiguation (via context triple) batch_69c11d2f43a88190a7a6834a7624998d completed March 23, 2026, 10:59 a.m.
Created at: March 22, 2026, 4:10 p.m.